AstraZeneca Pharma India Ltd. — Board/Management Information 2022

Oct 31, 2022

==> picture [524 x 91] intentionally omitted <==

October 31, 2022

The Manager - Listing National Stock Exchange of India Ltd. Exchange plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai 400051

The Manager - Listing BSE Limited Corporate Relationship Dept., 1[st] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai 400001

Dear Sir(s),

Sub: Meeting of the Board of Directors of the Company to be held on Friday, November 11, 2022 – Ref: Scrip Code BSE: 506820, NSE: ASTRAZEN

This is to inform you that the Meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Friday, November 11, 2022 inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022.

We would also like to inform you that the ‘Trading Window’ remains closed for all Designated Persons, from September 16, 2022 to November 13, 2022 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.

We request you to please take the same on record.

Thanking you,

Yours faithfully

For AstraZeneca Pharma India Limited

Digitally signed MANAS by MANASA RAMA A RAMA Date: 2022.10.31 16:51:10 +05'30'

Manasa. R Company Secretary

==> picture [452 x 64] intentionally omitted <==